• PExA will exhibit at the European Respiratory Society (ERS) International Congress 2026 in Barcelona on Sept. 5-9, 2026.
• Three research abstracts using its technology were accepted for presentation, covering progressive pulmonary fibrosis, idiopathic pulmonary fibrosis, and COPD.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PExA AB published the original content used to generate this news brief via Cision (Ref. ID: 202609030818BITN____UKPR__SV_20260903-BIT-6077-0) on September 03, 2026, and is solely responsible for the information contained therein.